Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125980101 | 12598010 | 1 | I | 20160715 | 20160727 | 20160727 | EXP | JP-TEVA-679797ISR | TEVA | YAMASHINA T, TAKADA R, UEDO N, AKASAKA T, HANAOKA N, TAKEUCHI Y ET AL. PROSPECTIVE SMALL BOWEL MUCOSAL ASSESSMENT IMMEDIATELY AFTER CHEMORADIOTHERAPY OF UNRESECTABLE LOCALLY ADVANCED PANCREATIC CANCER USING CAPSULE ENDOSCOPY: A CASE SERIES. ANNALS OF GASTROENTEROLOGY. 2016; 29(3):386-388 | 7.00 | DEC | M | Y | 0.00000 | 20160727 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125980101 | 12598010 | 1 | PS | GEMCITABINE | GEMCITABINEGEMCITABINE HYDROCHLORIDE | 1 | WEEKLY | U | 77983 | 1000 | MG/M**2 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125980101 | 12598010 | 1 | Pancreatic carcinoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125980101 | 12598010 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125980101 | 12598010 | Decreased appetite | |
| 125980101 | 12598010 | Duodenitis | |
| 125980101 | 12598010 | Enteritis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |